Why the study?
The mechanisms underlying the anti-apoptotic effects of G-CSF in diabetic cardiomyopathy were not fully understood.
Does granulocyte-colony stimulating factor (G-CSF) reduce cardiomyocyte apoptosis by up-regulating autophagy in a model of diabetic cardiomyopathy?
Does granulocyte-colony stimulating factor (G-CSF) reduce cardiomyocyte apoptosis by up-regulating autophagy in a model of diabetic cardiomyopathy?
G-CSF attenuates cardiomyocyte apoptosis in diabetic cardiomyopathy by up-regulating autophagy, highlighting a potential mechanistic pathway for treating diabetic heart disease.
Answers are grounded in this paper and cite their sources.
Autophagy may mediate G-CSF anti-apoptotic effects in diabetic cardiomyopathy models; hypothesis-generating, clinical translation untested.
BACKGROUND: We previously, reported that granulocyte-colony stimulating factor (G-CSF) reduces cardiomyocyte apoptosis in diabetic cardiomyopathy. However, the underlying mechanisms are not yet fully understood. Therefore, we investigated whether the mechanisms underlying of the anti-apoptotic effects of G-CSF were associated with autophagy using a rat model of diabetic cardiomyopathy. METHODS: Diabetic cardiomyopathy was induced in rats through a high-fat diet combined with low-dose streptozotocin and the rats were then treated with G-CSF for 5 days. Rat H9c2 cardiac cells were cultured under high glucose conditions as an in vitro model of diabetic cardiomyopathy. The extent of apoptosis and protein levels related to autophagy (Beclin-1, microtubule-binding protein light chain 3 [LC3]-II/LC3-I ratio, and P62) were determined for both models. Autophagy determination was performed using an Autophagy Detection kit. RESULTS: G-CSF significantly reduced cardiomyocyte apoptosis in the diabetic myocardium in vivo and led to an increase in Beclin-1 level and the LC3-II/LC3-I ratio, and decreased P62 level. Similarly, G-CSF suppressed apoptosis, increased Beclin-1 level and LC3-II/LC3-I ratio, and decreased P62 level in high glucose-induced H9c2 cardiac cells in vitro. These effects of G-CSF were abrogated by 3-methyladenine, an autophagy inhibitor. In addition, G-CSF significantly increased autophagic flux in vitro. CONCLUSION: Our results suggest that the anti-apoptotic effect of G-CSF might be significantly associated with the up-regulation of autophagy in diabetic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: